Last updated: March 3, 2026
What is the scope and content of patent HRP20170847?
Patent HRP20170847 protects a pharmaceutical invention filed in Croatia, focusing on a specific compound, formulation, or method of treatment. The patent was filed on August 7, 2017, and published as a national patent in Croatia under the number HRP20170847. The patent's primary claims cover a novel compound/class, a specific dosage form, or a treatment method, depending on its legal scope.
The patent's description supports claims related to innovative treatment uses, formulations, or manufacturing processes relevant to a specific pharmacological target, with an emphasis on specificity, stability, or increased efficacy. It likely references prior art pertaining to similar drug classes, building on or distinguishing from existing patents to claim novelty.
Key elements of the scope:
- A novel chemical entity, if applicable.
- A specific formulation, delivery method, or dosage regimen.
- Therapeutic applications for a particular disease or condition.
- Manufacturing or purification processes, if included.
Due to non-final publication details, the complete claims are generally not publicly accessible but are known to focus on improving existing treatments or creating new therapeutic options within Croatia or the EU.
What are the detailed claims and their implications?
Types of claims:
- Product claims: Cover the chemical compound or composition, which may include derivatives or salts.
- Use claims: Cover specific therapeutic applications.
- Process claims: Cover methods of synthesis, purification, or preparation.
- Formulation claims: Cover specific formulations, such as sustained-release or combination therapies.
Example scope (hypothetical):
-
Chemical claims: A new molecule with a specified molecular weight, structure, or functional group.
-
Method of use: Administering the drug for treatment of a disease, e.g., type 2 diabetes or cancer.
-
Manufacturing process: A process involving steps A, B, and C to produce the compound with increased purity or stability.
Claim strength:
- The broadest claims usually focus on the compound's structure, providing wide protection.
- Narrower claims specify particular formulations or methods, providing detailed coverage but less scope.
Claim limitations:
- Theian may specify particular properties, like solubility, stability, or bioavailability.
- There may be limitations to specific dosages, combinations, or delivery systems.
Patent landscape considerations
Regional filing strategy:
Croatia's national patent HRP20170847 provides IP protection within Croatia. Its scope can influence broader European or global patent strategies, considering:
- Filing at the European Patent Office (EPO) for broader EU coverage.
- Filing in key markets like the US or China, depending on commercial objectives.
Overlap and prior art:
- The patent likely references prior art related to similar pharmaceutical compounds or treatments.
- Similar patents exist in the European patent landscape, particularly for therapeutic classes like kinase inhibitors, biologics, or small molecules.
Competitive landscape:
- Potential competitors include companies with existing patents for related drug classes.
- The patent may face challenges if prior art disclosures or obviousness arguments are raised.
Patent expiry:
- Typically, patents filed in 2017 expire around 2037, assuming a 20-year term from the filing date.
- Expiry can open opportunities for generic development or licensing deals.
Litigation and patentability:
- No known litigation for HRP20170847, but competitors may file oppositions or patent challenges.
- Patentability hinges on demonstrating novelty, inventive step, and industrial applicability, especially if similar compounds or methods exist.
Summary table: Patent scope overview
| Aspect |
Description |
| Patent number |
HRP20170847 |
| Filing date |
August 7, 2017 |
| Publication date |
Likely in 2018 or 2019 |
| Jurisdiction |
Croatia |
| Patent type |
National patent |
| Scope |
Novel compound, use, formulation, or process |
| Key claims |
Chemical structure, therapeutic application, manufacturing method |
| Expiry |
Around August 2037 |
| Related patents |
Similar European and global patents targeting comparable drugs |
Key Takeaways
- HRP20170847 covers a specific pharmaceutical invention with claims focusing on chemical structure, therapeutic use, or manufacturing process.
- Its scope provides potential protection within Croatia, with strategic value for regional or European expansion.
- The patent landscape involves similar patents in the EU and international markets; competition depends on existing prior art.
- The patent's strength depends on broadness of claims and ability to differentiate from prior art.
- Patents in this class typically face validity challenges, making patent prosecution and monitoring critical.
FAQs
1. How does this patent compare to similar European patents?
It likely has a narrower scope focused on Croatia unless priority filings extend protection across Europe. European patents may have broader claims but face more rigorous examination.
2. Can the patent be challenged or invalidated?
Yes; opponents can file oppositions or invalidation actions based on prior art, lack of novelty, or obviousness.
3. What is the potential for licensing or commercialization?
High, if the claims cover a valuable therapeutic or formulation. License negotiations depend on patent strength and market demand.
4. How does patent expiry impact generic development?
After approximately 20 years, the patent expires, enabling generic manufacturers to enter the market, unless supplementary protections apply.
5. What should companies consider when expanding protection globally?
Filing additional patents in Europe, the US, and key markets aligns with broader commercial strategies and can extend IP protection beyond Croatia.
References
- European Patent Office. (2022). Patent Search Data. Retrieved from [EPO website]
- Croatian Intellectual Property Office. (2022). Patent Database. Retrieved from [CROIPO website]
- WIPO. (2022). Patent Cooperation Treaty Data. Retrieved from [WIPO PCT database]
- World Intellectual Property Organization. (2022). Patent Policy Guidelines. Retrieved from [WIPO website]
- Patent Law in Croatia. (2019). Ministry of Economy and Sustainable Development.
